| Literature DB >> 36124312 |
Masakazu Imaoka1,2,3,4, Hidetoshi Nakao1,2, Misa Nakamura1,2, Fumie Tazaki1,2, Mitsumasa Hida1,2, Ryota Imai1,2, Motohiro Maebuchi5, Masahisa Ibuki6, Masatoshi Takeda1,2.
Abstract
Background: Soy peptide, when consumed as a functional food, has been reported to improve cognitive function. This study aimed to verify the combined effect of soy peptide supplementation and exercise on cognitive function among community-dwelling older adults in Japan.Entities:
Keywords: ACE-R, Addenbrooke's Cognitive Examination-Revised; ANOVA, analysis of variance; BDNF, brain-derived neurotropic factor; Dietary supplements; Elderly; Ex, exercise-only group; Ex + Nt, exercise plus nutrition group; GDS-15, Geriatric Depression Scale 15; MMSE, Mini-Mental State Examination; Memory; Motor function; SMI, skeletal muscle mass index; SPI, soy protein isolate
Year: 2022 PMID: 36124312 PMCID: PMC9482121 DOI: 10.1016/j.conctc.2022.100998
Source DB: PubMed Journal: Contemp Clin Trials Commun ISSN: 2451-8654
Total calories and chemical composition of soybean.
| Total calories (kcal) | 48 |
|---|---|
| Protein (g) | 4.4 |
| Fat (g) | 0 |
| Carbohydrate (g) | 8.9 |
| Sodium (mg) | 112 |
| Valine (mg) | 184 |
| Leucine (mg) | 300 |
| Isoleucine (mg) | 177 |
| Soybean peptide (mg) | 4000 |
Fig. 1Flowchart of trial participation.
Baseline characteristics of the study participants.
| Characteristics | Overall (n = 72) | Ex + Nt group (n = 36) | Ex group (n = 36) | F-value | p-value |
|---|---|---|---|---|---|
| Age | 74.7 ± 5.1 | 74.7 ± 4.8 | 74.7 ± 5.4 | 1.233 | 1.000 |
| Height, cm | 154.6 ± 7.3 | 153.8 ± 7.8 | 155.3 ± 6.7 | 0.606 | 0.405 |
| Weight, kg | 53.5 ± 8.9 | 52.6 ± 8.9 | 54.5 ± 9.0 | 0.002 | 0.308 |
| Females, n % | 59 (81.9%) | 28 (77.8%) | 31 (86.1%) | 0.271 | |
| ACE-R, score | 91.5 ± 6.7 | 90.5 ± 7.4 | 92.6 ± 4.8 | 1.416 | 0.203 |
| TMT-A, sec | 102.1 ± 37.1 | 105.3 ± 38.2 | 96.8 ± 33.3 | 0.026 | 0.217 |
| Gait speed, m/s | 1.40 ± 0.20 | 1.37 ± 0.17 | 1.43 ± 0.23 | 2.260 | 0.271 |
| Grip strength, kg | 23.3 ± 6.0 | 23.3 ± 5.5 | 23.3 ± 6.7 | 0.936 | 0.947 |
| SMI, kg/m2 | 5.94 ± 0.90 | 5.93 ± 0.87 | 5.95 ± 0.93 | 0.893 | 0.805 |
| GDS, score | 3.1 ± 2.6 | 2.8 ± 2.4 | 3.3 ± 2.7 | 0.171 | 0.667 |
Notes: Data are presented as the mean ± standard deviation or numbers (percentages). Abbreviations: Ex group, participants allocated to an exercise program; Ex + Nt group, participants allocated to a combined exercise and soy peptide intake program.
Pre- and post-intervention outcome measurements in the two groups.
| Pre-intervention | Post-intervention | Two-way ANOVA | |||||
|---|---|---|---|---|---|---|---|
| Time Effect | Time × Group Interaction | ||||||
| F-value | p-value | F-value | p-value | ||||
| ACE-R (score) | |||||||
| Ex + Nt | 90.5 ± 7.4 | 90.2 ± 8.9 | 1.78 | 0.19 | 0.30 | 0.59 | |
| Ex | 92.6 ± 4.8 | 92.0 ± 6.4 | |||||
| TMT-A (s) | |||||||
| Ex + Nt | 105.3 ± 38.2 | 104.0 ± 39.7 | 0.30 | 0.59 | 0.81 | 0.37 | |
| Ex | 96.8 ± 33.3 | 88.7 ± 24.7 | |||||
| Gait speed (m/s) | |||||||
| Ex + Nt | 1.37 ± 0.17 | 1.34 ± 0.17 | 2.25 | 0.14 | 0.00 | 0.97 | |
| Ex | 1.43 ± 0.23 | 1.42 ± 0.17 | |||||
| Grip strength (kg) | |||||||
| Ex + Nt | 23.3 ± 5.5 | 23.3 ± 6.1 | 1.25 | 0.27 | 2.51 | 0.12 | |
| Ex | 23.3 ± 6.7 | 24.7 ± 6.7 | |||||
| SMI (kg/m2) | |||||||
| Ex + Nt | 5.93 ± 0.87 | 6.04 ± 0.93 | 21.20 | <0.05* | 0.36 | 0.55 | |
| Ex | 5.95 ± 0.93 | 6.13 ± 0.90 | |||||
| GDS (score) | |||||||
| Ex + Nt | 2.8 ± 2.4 | 2.40 ± 2.12 | 3.27 | 0.08 | 0.77 | 0.40 | |
| Ex | 3.3 ± 2.7 | 3.00 ± 2.90 | |||||
Notes: Data are presented as the mean ± standard deviation.
Abbreviations: Ex group, participants allocated to an exercise program; Ex + Nt group, participants allocated to a combined exercise and soy peptide intake program; ACE-R, Addenbrooke's Cognitive Examination-Revised; TMT, Trail-making test; IGF-1, insulin-like growth factor 1; SMI, skeletal muscle mass index; GDS, Geriatric Depression Scale.
*p < 0.05.
Pre- and post-intervention ACE-R cognitive domain, task, and subtotal scores.
| Pre-intervention | Post-intervention | Two-way ANOVA | |||||
|---|---|---|---|---|---|---|---|
| Time Effect | Time × Group Interaction | ||||||
| F-value | p-value | F-value | p-value | ||||
| Attention | |||||||
| Ex + Nt | 17.7 ± 0.6 | 17.5 ± 1.2 | 0.66 | 0.42 | 1.11 | 0.30 | |
| Ex | 17.8 ± 0.4 | 17.8 ± 0.4 | |||||
| Memory | |||||||
| Ex + Nt | 21.2 ± 4.3 | 21.5 ± 4.5 | 1.89 | 0.18 | 4.53 | <0.05* | |
| Ex | 22.7 ± 3.1 | 21.3 ± 3.8 | |||||
| Fluency | |||||||
| Ex + Nt | 12.3 ± 2.2 | 11.6 ± 2.8 | 2.28 | 0.14 | 1.14 | 0.29 | |
| Ex | 12.9 ± 1.5 | 12.8 ± 2.1 | |||||
| Language | |||||||
| Ex + Nt | 24.3 ± 1.9 | 24.5 ± 1.7 | 2.51 | 0.12 | 0.12 | 0.74 | |
| Ex | 24.3 ± 1.4 | 24.6 ± 1.7 | |||||
| Visuospatial | |||||||
| Ex + Nt | 15.2 ± 1.1 | 15.1 ± 1.1 | 1.64 | 0.21 | 2.41 | 0.13 | |
| Ex | 15.4 ± 0.7 | 15.8 ± 0.6 | |||||
Notes: Data are presented as the mean ± standard deviation.
Abbreviations: Ex group, participants allocated to an exercise program; Ex + Nt group, participants allocated to a combined exercise and soy peptide intake program; ACE-R, Addenbrooke's Cognitive Examination-Revised. *p < 0.05.